Prime Medicine, founded by David Liu, is finding that the path of translating scientific breakthroughs to treatments is ...

Opinion: “Exposed” by Wendy Kline shows how the pelvic exam exemplifies questions about gender, medicine, and power.

Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs ...

Stanford professor James Zou examined the clinical adoption of medical AI devices, and found that only a handful are being ...

The CDC said an investigation into a human H5N1 bird flu infection in Missouri has found four additional health care workers ...

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...

The authors have each served as director of the Centers for Disease Control and Prevention. One misguided narrative is that the CDC should focus only on a “core mission” of combatting ...

Two Democratic lawmakers are working to preserve health providers’ right to prescribe controlled substances via telehealth, including stimulants for ADHD and buprenorphine for opioid addiction.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

Dhillon is an instructor in the Division of Global Health Equity at Brigham and Women’s Hospital and Harvard Medical School.

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

What comes next for Pfizer's Oxbryta sickle cell drug —Cassava Sciences' SEC charges —Bristol's new schizophrenia treatment ...